ARIAD to Present at the Jefferies 2015 Global Healthcare Conference
May 21 2015 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
it will present at the Jefferies 2015 Global Healthcare Conference
being held in New York City. Timothy P. Clackson, Ph.D., president
of research and development and chief scientific officer, will
provide an overview of the Company’s business on Thursday, June 4,
2015 at 1:00 p.m. (ET).
The ARIAD presentation will be webcast live and can be accessed
by visiting the investor relations section of the Company's website
at http://www.ariad.com/investor. A replay of the presentation will
also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts and Lausanne, Switzerland, is an integrated global
oncology company focused on transforming the lives of cancer
patients with breakthrough medicines. ARIAD is working on new
medicines to advance the treatment of various forms of chronic and
acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer
medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150521005064/en/
ARIAD Pharmaceuticals, Inc.For InvestorsKendra Adams,
617-503-7028Kendra.adams@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Oct 2023 to Oct 2024